Nice, I have been in NVDIA and TSLA for a very long time as well. The management there didn’t have a history of BSing like what we have. They didn’t get delisted from a major exchange. They stayed compliant throughout their struggles and didn’t blame shorts and played victim card when they were struggling. They didn’t shy away from communicating with the investors and street about their vision. In our case, it almost appears that they are hiding something by staying in this so called quiet period (2 years since data lock) and not going all out to convince investors and street.
And you know as well as I do that techs and biotechs are very different. Biotech are regulated and hence the valuations don’t fly as high and as quickly as techs. You have got to run trials, convince regulatory authorities, work on reimbursement with various governments, etc.
News 
Market Data 
Discover 
